2006
DOI: 10.1016/s1470-2045(06)70584-8
|View full text |Cite
|
Sign up to set email alerts
|

Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

15
437
0
4

Year Published

2007
2007
2017
2017

Publication Types

Select...
5
1

Relationship

3
3

Authors

Journals

citations
Cited by 395 publications
(461 citation statements)
references
References 32 publications
15
437
0
4
Order By: Relevance
“…In terms of diagnostic accuracy, CE-MS also favourably compares to urinary Gb 3 , for which an AUC of 0.876 has been reported [33] (vs. 0.970 for CE-MS in our study), although lyso-Gb 3 seems to perform better than total Gb 3 [34]. In addition, because similarly accurate CE-MS based diagnostic models have been developed for a variety of other renal and cardiovascular diseases [13], [35], [36], [37], [38], [39], CE-MS may give hints to an alternative diagnosis in Fabry negative patients, i.e. this approach may offer an efficient diagnostic method, which can detect a variety of diseases using a single diagnostic test.…”
Section: Discussionsupporting
confidence: 48%
See 4 more Smart Citations
“…In terms of diagnostic accuracy, CE-MS also favourably compares to urinary Gb 3 , for which an AUC of 0.876 has been reported [33] (vs. 0.970 for CE-MS in our study), although lyso-Gb 3 seems to perform better than total Gb 3 [34]. In addition, because similarly accurate CE-MS based diagnostic models have been developed for a variety of other renal and cardiovascular diseases [13], [35], [36], [37], [38], [39], CE-MS may give hints to an alternative diagnosis in Fabry negative patients, i.e. this approach may offer an efficient diagnostic method, which can detect a variety of diseases using a single diagnostic test.…”
Section: Discussionsupporting
confidence: 48%
“…Control urine samples were taken from healthy volunteers and patients with a variety of other renal, metabolic and cardiovascular diseases. These samples have been previously collected as part of several clinical studies (refs [13], [35], [36], [37], [38], [39] and as yet unpublished studies). All samples were collected in the morning from midstream urine, frozen at −20°C without prior centrifugation and without addition of protease inhibitors, as suggested in recently published recommendations [42].…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations